GaryStevenHorwithMD
Infectious Disease • Gaithersburg, MDMedical Officer / Sr Subject Matter Expert in Pharmacovigilance supporting the Biomedical Advanced Research and Development Authority (BARDA), Assistant Secretary for Preparedness and Response (ASPR), Health and Human Services
Dr. Horwith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9001 Goshen Valley Dr
Gaithersburg, MD 20882Phone+1 301-602-7401
Education & Training
University of California (Irvine)Fellowship, Infectious Disease, 1979 - 1981
University of Connecticut (New Britain)Residency, Internal Medicine, 1976 - 1979
Universidad Autonoma de GuadalajaraClass of 1975
Certifications & Licensure
CA State Medical License 1979 - Present
NY State Medical License 1976 - Present
PA State Medical License 1985 - 2024- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Safety and Effectiveness of NicVAX in Treating Nicotine Dependent Individuals Start of enrollment: 2004 Oct 01
Publications & Presentations
PubMed
- 337 citationsUse of a Staphylococcus aureus Conjugate Vaccine in Patients Receiving HemodialysisHenry R. Shinefield, Steven Black, Ali Fattom, Gary Horwith, Scott A. Rasgon
The New England Journal of Medicine. 2002-02-14 - 136 citationsSafety and immunogenicity of a nicotine conjugate vaccine in current smokers.Dorothy K. Hatsukami, Stephen I. Rennard, Douglas E. Jorenby, Mph Michael Fiore Md, Joseph S. Koopmeiners
Clinical Pharmacology and Therapeutics. 2005-11-01 - 72 citationsSafety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX) in hemodialysis patients.Ali Fattom, Steve Fuller, Myra Propst, Scott Winston, Larry R. Muenz
Vaccine. 2004-12-16
Professional Memberships
- American Society of MicrobiologyMember
- Member
Industry Relationships
- Chief Medical Officer & Head of Regulatory Affairs, Sequella2006 - 2013
- Clinical VP, Nabi Biopharmaceuticals1997 - 2006
- Sr. Medical Director, The Liposome Company1994 - 1997
- Clinical, Wyeth-Ayerst1984 - 1994
- Investigator, US Army Institute of Infectious Diseases1981 - 1984
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
